Graceway Pharmaceuticals, LLC  Bankruptcy New Filing Alert: Required Bankruptcy Report Regarding Schedules Of Assets And Liabilities, Statement Of Financial Affairs, Monthly Operating Report Or Other Periodic Report

On January 15, 2015, a required bankruptcy report regarding schedules of assets and liabilities, statement of financial affairs, monthly operating report or other periodic report was filed in the bankruptcy case of Graceway Pharmaceuticals, LLC  and its affiliates.

The filing was assigned docket number 1088 and is described on the court’s official docket as follows:

Post-Confirmation Report – Post-Confirmation Quarterly Summary Report Filed by Kip Horton. (Brogan, Daniel)

Graceway Pharmaceuticals, LLC  filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on September 29, 2011. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 11-13036. The bankruptcy case is currently assigned to United States Bankruptcy Judge Peter Walsh. The law firm of Latham & Watkins LLP is acting as lead bankruptcy counsel to Graceway Pharmaceuticals, LLC  in the bankruptcy case.


Leave a Reply